Trademark: 79358612
Word
NUACRES
Status Date
Monday, April 29, 2024
Filing Date
Monday, November 7, 2022
5 Medical and veterinary preparations for the treatment of neoplastic pathologies and infectious diseases; pharmaceuticals, namely, vaccines; biomedical pharmaceutical products for the treatment of neoplastic pathologies and infectious diseases; clinical diagnostic reagents for medical use; therapeutical agent substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); Prophylactical agent substances in the nature of infection prophylactic agents and cancer prophylactic agents; pharmaceutical products, particularly for the field of oncology and infectiology all in the nature of pharmaceutical products for the prevention and treatment of cancer and infectious diseases; biomedical products based on cytological research substances all in the nature of oligo- and poly-nucleotides and nucleic acid antibodies (aptamers); pharmaceuticals, particularly for the use in algorithm supported medical treatment all in the nature of pharmaceuticals for treating of infectious diseases and cancer; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleotids and nucleic acid antibodies (aptamers) and reagents as part of medical and veterinary preparations; chemical or biological substances in the nature of oligo- and poly-nucleotides and nucleic acid antibodies all for the treatment of cancer and infectious diseases and reagents for medical and veterinary use; agonists for medical and veterinary use; TLR agonists for medical and veterinary use; agonists as part of medical and veterinary preparations; TLR agonists as part of medical and veterinary preparations
1 Chemical or biological substances in the nature of Oligo- and poly-nucleotide arrays for scientific and medical research and reagents for scientific purposes; Chemical or biological substances, namely, molecular constructs made of DNA or RNA to serve as reagents for research in the field of diagnostics; Chemical or biological molecular constructs made of DNA or RNA for scientific or medical research use; Chemicals and chemical preparations for use in agriculture, horticulture and forestry except fungicides, herbicides, insecticides and parasiticides
44 Medical treatments, particularly in the field of oncology and infectiology; medical analysis services related to the treatment of patients, particularly in the field of oncology and infectiology; medical services in connection with the treatment of cancer; medical testing in connection with the diagnosis and treatment of diseases, particularly in the field of oncology and infectiology; medical testing for diagnostic or treatment purposes, particularly in the field of oncology and infectiology; medical treatments based on clinical treatment algorithms, particularly in the field of oncology and infectiology; performance of medical tests related to the diagnosis and treatment of cancer; medical examinations for the diagnosis or treatment of cancer; medical treatments of cancer based on clinical treatment algorithms; medical equipment rental, particularly for computer aided treatments; medical services; pharmaceutical services, namely, procurement and monitoring of drug therapy of cancer and infectious diseases; computer-assisted medical assessment and diagnostical services
42 Technical services relating to pharmaceutical and medical preparations, pharmaceuticals and drugs, namely, technical research in the field of using computers to diagnose disease and health conditions; provision of information relating to medical and veterinary research and development, particularly in the field of oncology and infectiology; providing an on-line searchable database in the fields of medical and veterinary research and development, particularly in the field of oncology and infectiology; research and development for the pharmaceutical industry, particularly in the field of oncology and infectiology; biomedical research services; research and development services in the field of oncology; research and development services in the field of infectiology; research and development of biomolecules, cells and cellular products for medical use; research and development of biomedical products, particularly therapeutical and prophylactic substances for medical use in the field of oncology and infectiology; research and development in the field of clinical treatment algorithms; medical laboratory services; computer diagnostic services, particularly based on clinical treatment algorithms; computer diagnostic services, particularly in the field of oncology; computer diagnostic services, particularly in the field of infectiology; development of diagnostic apparatus for computer aided medical treatment
Dec 27, 2022
New Application Office Supplied Data Entered
Dec 31, 2022
Application Filing Receipt Mailed
Dec 23, 2022
Sn Assigned For Sect 66a Appl From Ib
Aug 22, 2023
Assigned To Examiner
Sep 7, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Sep 25, 2023
Refusal Processed By Mpu
Sep 6, 2023
Non-Final Action Written
Sep 25, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Oct 17, 2023
Refusal Processed By Ib
Mar 7, 2024
Correspondence Received In Law Office
Mar 7, 2024
Teas/Email Correspondence Entered
Mar 7, 2024
Teas Response To Office Action Received
Apr 17, 2024
Approved For Pub - Principal Register
Apr 19, 2024
Withdrawn From Pub - Senior Attorney Request
Jun 7, 2024
Notification Of Possible Opposition Sent To Ib
Jun 7, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 7, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 29, 2024
Previous Allowance Count Withdrawn
Trademark Alertz updated from USPTO on 2030-01-24
